InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Ingalls Kerry D.. Officer active across 1 companies, notably Poseida Therapeutics, Inc.. Cumulatively, 4 reports have been recorded. Total volume traded: €36k. The latest transaction was filed on 16 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€10,8853,000 shares@ €3.628330.6% of flow
Common Stock
SEC:0001209191-22-020153:0·
Ideal exit: 11 Dec 2022 (T+270)
050,000 shares0
Common Stock
SEC:0001209191-22-014377:0·
€12,3662,000 shares@ €6.1831100.0% of flow
Common Stock
SEC:0001209191-21-065673·
Ideal exit: 14 Aug 2022 (T+270)
€12,3662,000 shares@ €6.183134.7% of flow
Common Stock
SEC:0001209191-21-065673:0·
Ideal exit: 14 Aug 2022 (T+270)
4 of 4 declarations
